Contact Us
In-vitro Colorectal Cancer Screening Tests Global Market Report 2025
Global In-vitro Colorectal Cancer Screening Tests Market Report 2025
Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

In-vitro Colorectal Cancer Screening Tests Global Market Report 2025

By Test Type (Fecal Occult Blood Test, Stool Deoxyribonucleic Acid Test, Blood Biomarker Test, Other Test Types), By Imaging Type (Colonoscopy, Proctoscopy, Computed Tomography Scan, Ultrasound, Magnetic Resonance Imaging, Positron Emission Tomography Scan), By Application (Screening, Diagnosis, Monitoring, Risk Assessment, Post-Treatment Surveillance), By End User (Hospitals, Diagnostic Laboratories, Outpatient Clinics, Home Care Settings, Research Institutions) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

In-vitro Colorectal Cancer Screening Tests Market Overview

• In-vitro Colorectal Cancer Screening Tests market size has reached to $1.21 billion in 2024

• Expected to grow to $1.71 billion in 2029 at a compound annual growth rate (CAGR) of 7%

• Growth Driver: Rising Prevalence Of Colorectal Cancer Fueling The Growth Of The Market Due To Increasing Risk From Unhealthy Lifestyles

• Market Trend: Innovative Non-Invasive Test Enhances Patient Screening Experience

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under In-vitro Colorectal Cancer Screening Tests Market?

In-vitro colorectal cancer screening tests are non-invasive laboratory-based tests that analyze stool or blood samples to detect signs of colorectal cancer or precancerous conditions. These tests help detect early signs of colorectal cancer in asymptomatic individuals, enabling early intervention and reducing cancer-related mortality.

The main test types of in-vitro colorectal cancer screening tests are fecal occult blood test, stool deoxyribonucleic acid test, blood biomarker test, and others. The fecal occult blood test refers to a noninvasive diagnostic method used to detect hidden (occult) blood in the stool, which may be an early sign of colorectal cancer or other gastrointestinal disorders. The various imaging techniques include colonoscopy, proctoscopy, computed tomography scan, ultrasound, magnetic resonance imaging, and positron emission tomography scan, and support a wide range of applications, including screening, diagnosis, monitoring, risk assessment, and post-treatment surveillance, serving end users such as hospitals, diagnostic laboratories, outpatient clinics, home care settings, and research institutions.

In-vitro Colorectal Cancer Screening Tests Market Size and growth rate 2025 to 2029: Graph

What Is The In-vitro Colorectal Cancer Screening Tests Market Size 2025 And Growth Rate?

The in-vitro colorectal cancer screening tests market size has grown strongly in recent years. It will grow from $1.21 billion in 2024 to $1.30 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing awareness of early cancer detection, rise in government screening programs, increasing adoption of non-invasive testing methods, growing healthcare expenditure, and increasing availability of at-home screening kits.

What Is The In-vitro Colorectal Cancer Screening Tests Market Growth Forecast?

The in-vitro colorectal cancer screening tests market size is expected to see strong growth in the next few years. It will grow to $1.71 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing focus on personalized medicine, rising demand for cost-effective diagnostics, growing investments in cancer research, rising adoption of molecular diagnostic techniques, increasing prevalence of colorectal cancer, and increasing accessibility of testing in emerging markets. Major trends in the forecast period include advancement in liquid biopsy technologies, innovation in biomarker discovery, integration of artificial intelligence in test analysis, advanced development of multi-target stool deoxyribonucleic acid tests, innovation in sample collection and processing, advancement in automation and digital pathology, and integration of cloud-based diagnostic platforms.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The In-vitro Colorectal Cancer Screening Tests Market Segmented?

1) By Test Type: Fecal Occult Blood Test, Stool Deoxyribonucleic Acid Test, Blood Biomarker Test, Other Test Types

2) By Imaging Type: Colonoscopy, Proctoscopy, Computed Tomography Scan, Ultrasound, Magnetic Resonance Imaging, Positron Emission Tomography Scan

3) By Application: Screening, Diagnosis, Monitoring, Risk Assessment, Post-Treatment Surveillance

4) By End User: Hospitals, Diagnostic Laboratories, Outpatient Clinics, Home Care Settings, Research Institutions

Subsegments:

1) By Fecal Occult Blood Test: Guaiac Based Fecal Occult Blood Test, Immunochemical Fecal Occult Blood Test

2) By Stool Deoxyribonucleic Acid Test: Single Target Stool Deoxyribonucleic Acid Test, Multi Target Stool Deoxyribonucleic Acid Test

3) By Blood Biomarker Test: Methylated Septin 9 Deoxyribonucleic Acid Test, Circulating Tumor Deoxyribonucleic Acid Test, Protein Biomarker Based Blood Test

4) By Other Test Types: Urine Based Biomarker Test, Serum Based Biomarker Test, Breath Based Volatile Organic Compound Test

What Is Driving The In-vitro Colorectal Cancer Screening Tests Market? Rising Prevalence Of Colorectal Cancer Fueling The Growth Of The Market Due To Increasing Risk From Unhealthy Lifestyles

The rising prevalence of colorectal cancer is expected to propel the growth of the in vitro colorectal cancer screening tests market going forward. Colorectal cancer refers to a type of cancer that starts in the colon or rectum, often developing from precancerous polyps. The rising prevalence of colorectal cancer is due to unhealthy lifestyle habits, as poor diet, lack of exercise, and obesity increase the risk of polyp formation and cancer development. In-vitro colorectal cancer screening tests aid in colorectal cancer diagnosis by offering non-invasive methods to detect early signs of cancer. They improve screening accuracy through advanced biomarker detection, enhancing early intervention and patient outcomes. For instance, in February 2025, according to the American Cancer Society, a US-based nonprofit organization, the estimated number of new colorectal cancer cases was 154,270, an increase from 152,810 cases in 2024. Therefore, the rising prevalence of colorectal cancer is driving the growth of the in vitro colorectal cancer screening tests market.

Who Are The Major Players In The Global In-vitro Colorectal Cancer Screening Tests Market?

Major companies operating in the in-vitro colorectal cancer screening tests market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Quest Diagnostics Incorporated, Roche Diagnostics International AG, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Natera Inc., Leica Biosystems Nussloch GmbH, BGI Genomics Co. Ltd., NeoGenomics Inc., Guardant Health Inc., CellMax Life Inc., Epigenomics AG, Acuamark Diagnostics Inc., Beacon Biomedical Inc., Mainz Biomed NV.

What Are The Key Trends Of The Global In-vitro Colorectal Cancer Screening Tests Market? Innovative Non-Invasive Test Enhances Patient Screening Experience

Major companies operating in the in vitro colorectal cancer screening tests market are focusing on developing advanced diagnostic solutions, such as multi-target stool DNA tests, to improve early detection accuracy, enhance patient convenience, and reduce colorectal cancer mortality rates. Multi-target stool DNA tests refer to innovative screening tools that analyze stool samples for genetic and biochemical markers associated with colorectal cancer and precancerous lesions. For instance, in March 2025, Exact Sciences Corp., a US-based molecular diagnostics company, launched Cologuard Plus, an enhanced at-home colorectal cancer screening test for average-risk adults aged 45 and older. This test incorporates advanced biomarker technology, offering higher sensitivity and specificity compared to its predecessor. It utilizes a refined algorithm to detect DNA mutations and hemoglobin biomarkers, improving the detection of both colorectal cancer and advanced adenomas. The Cologuard Plus test provides a non-invasive and convenient screening option that eliminates the need for bowel preparation or dietary restrictions, thereby increasing patient adherence to recommended screening guidelines.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The In-vitro Colorectal Cancer Screening Tests Market? Mainz Biomed Partners With Labor Team W AG To Launch ColoAlert

In February 2025, Mainz Biomed N.V., a Germany-based biotech company, partnered with Labor Team W AG to jointly launch ColoAlert. This partnership aims to expand ColoAlert's availability across Switzerland, using Labor Team W AG’s diagnostic network to boost early colorectal cancer detection and improve patient outcomes. Labor Team W AG is a Switzerland-based diagnostic services company providing in-vitro colorectal cancer screening tests.

What Is The Regional Outlook For The Global In-vitro Colorectal Cancer Screening Tests Market?

North America was the largest region in the in-vitro colorectal cancer screening tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the In-vitro Colorectal Cancer Screening Tests Market?

The in-vitro colorectal cancer screening tests market consists of revenues earned by entities by providing services such as molecular diagnostic testing, lab sample collection and processing services, risk assessment and genetic counseling services, telehealth-based screening consultations, screening program management for institutions, and electronic health record (EHR) integration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The in vitro colorectal cancer screening tests market also includes sales of sample collection devices, automated screening instruments, sample preservation and transport systems, and digital diagnostic platforms. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the In-vitro Colorectal Cancer Screening Tests Industry?

The in-vitro colorectal cancer screening tests market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro colorectal cancer screening tests industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

In vitro Colorectal Cancer Screening Tests Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.30 billion
Revenue Forecast In 2034 $1.71 billion
Growth Rate CAGR of 7.0% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Test Type, Imaging Type, Application, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Quest Diagnostics Incorporated, Roche Diagnostics International AG, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Natera Inc., Leica Biosystems Nussloch GmbH, BGI Genomics Co. Ltd., NeoGenomics Inc., Guardant Health Inc., CellMax Life Inc., Epigenomics AG, Acuamark Diagnostics Inc., Beacon Biomedical Inc., Mainz Biomed NV.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. In-vitro Colorectal Cancer Screening Tests Market Characteristics

3. In-vitro Colorectal Cancer Screening Tests Market Trends And Strategies

4. In-vitro Colorectal Cancer Screening Tests Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global In-vitro Colorectal Cancer Screening Tests Growth Analysis And Strategic Analysis Framework

5.1. Global In-vitro Colorectal Cancer Screening Tests PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global In-vitro Colorectal Cancer Screening Tests Market Growth Rate Analysis

5.4. Global In-vitro Colorectal Cancer Screening Tests Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global In-vitro Colorectal Cancer Screening Tests Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global In-vitro Colorectal Cancer Screening Tests Total Addressable Market (TAM)

6. In-vitro Colorectal Cancer Screening Tests Market Segmentation

6.1. Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Fecal Occult Blood Test

Stool Deoxyribonucleic Acid Test

Blood Biomarker Test

Other Test Types

6.2. Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Colonoscopy

Proctoscopy

Computed Tomography Scan

Ultrasound

Magnetic Resonance Imaging

Positron Emission Tomography Scan

6.3. Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Screening

Diagnosis

Monitoring

Risk Assessment

Post-Treatment Surveillance

6.4. Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Laboratories

Outpatient Clinics

Home Care Settings

Research Institutions

6.5. Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Fecal Occult Blood Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Guaiac Based Fecal Occult Blood Test

Immunochemical Fecal Occult Blood Test

6.6. Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Stool Deoxyribonucleic Acid Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single Target Stool Deoxyribonucleic Acid Test

Multi Target Stool Deoxyribonucleic Acid Test

6.7. Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Blood Biomarker Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Methylated Septin 9 Deoxyribonucleic Acid Test

Circulating Tumor Deoxyribonucleic Acid Test

Protein Biomarker Based Blood Test

6.8. Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Urine Based Biomarker Test

Serum Based Biomarker Test

Breath Based Volatile Organic Compound Test

7. In-vitro Colorectal Cancer Screening Tests Market Regional And Country Analysis

7.1. Global In-vitro Colorectal Cancer Screening Tests Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global In-vitro Colorectal Cancer Screening Tests Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market

8.1. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In-vitro Colorectal Cancer Screening Tests Market

9.1. China In-vitro Colorectal Cancer Screening Tests Market Overview

9.2. China In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In-vitro Colorectal Cancer Screening Tests Market

10.1. India In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In-vitro Colorectal Cancer Screening Tests Market

11.1. Japan In-vitro Colorectal Cancer Screening Tests Market Overview

11.2. Japan In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In-vitro Colorectal Cancer Screening Tests Market

12.1. Australia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In-vitro Colorectal Cancer Screening Tests Market

13.1. Indonesia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In-vitro Colorectal Cancer Screening Tests Market

14.1. South Korea In-vitro Colorectal Cancer Screening Tests Market Overview

14.2. South Korea In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In-vitro Colorectal Cancer Screening Tests Market

15.1. Western Europe In-vitro Colorectal Cancer Screening Tests Market Overview

15.2. Western Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In-vitro Colorectal Cancer Screening Tests Market

16.1. UK In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In-vitro Colorectal Cancer Screening Tests Market

17.1. Germany In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In-vitro Colorectal Cancer Screening Tests Market

18.1. France In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In-vitro Colorectal Cancer Screening Tests Market

19.1. Italy In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In-vitro Colorectal Cancer Screening Tests Market

20.1. Spain In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market

21.1. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market Overview

21.2. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In-vitro Colorectal Cancer Screening Tests Market

22.1. Russia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In-vitro Colorectal Cancer Screening Tests Market

23.1. North America In-vitro Colorectal Cancer Screening Tests Market Overview

23.2. North America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In-vitro Colorectal Cancer Screening Tests Market

24.1. USA In-vitro Colorectal Cancer Screening Tests Market Overview

24.2. USA In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In-vitro Colorectal Cancer Screening Tests Market

25.1. Canada In-vitro Colorectal Cancer Screening Tests Market Overview

25.2. Canada In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In-vitro Colorectal Cancer Screening Tests Market

26.1. South America In-vitro Colorectal Cancer Screening Tests Market Overview

26.2. South America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In-vitro Colorectal Cancer Screening Tests Market

27.1. Brazil In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In-vitro Colorectal Cancer Screening Tests Market

28.1. Middle East In-vitro Colorectal Cancer Screening Tests Market Overview

28.2. Middle East In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In-vitro Colorectal Cancer Screening Tests Market

29.1. Africa In-vitro Colorectal Cancer Screening Tests Market Overview

29.2. Africa In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In-vitro Colorectal Cancer Screening Tests Market Competitive Landscape And Company Profiles

30.1. In-vitro Colorectal Cancer Screening Tests Market Competitive Landscape

30.2. In-vitro Colorectal Cancer Screening Tests Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Roche Diagnostics International AG Overview, Products and Services, Strategy and Financial Analysis

31. In-vitro Colorectal Cancer Screening Tests Market Other Major And Innovative Companies

31.1. Illumina Inc.

31.2. Sysmex Corporation

31.3. Bio-Rad Laboratories Inc.

31.4. Qiagen N.V.

31.5. Exact Sciences Corporation

31.6. Natera Inc.

31.7. Leica Biosystems Nussloch GmbH

31.8. BGI Genomics Co. Ltd.

31.9. NeoGenomics Inc.

31.10. Guardant Health Inc.

31.11. CellMax Life Inc.

31.12. Epigenomics AG

31.13. Acuamark Diagnostics Inc.

31.14. Beacon Biomedical Inc.

31.15. Mainz Biomed NV

32. Global In-vitro Colorectal Cancer Screening Tests Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In-vitro Colorectal Cancer Screening Tests Market

34. Recent Developments In The In-vitro Colorectal Cancer Screening Tests Market

35. In-vitro Colorectal Cancer Screening Tests Market High Potential Countries, Segments and Strategies

35.1 In-vitro Colorectal Cancer Screening Tests Market In 2029 - Countries Offering Most New Opportunities

35.2 In-vitro Colorectal Cancer Screening Tests Market In 2029 - Segments Offering Most New Opportunities

35.3 In-vitro Colorectal Cancer Screening Tests Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Fecal Occult Blood Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Stool Deoxyribonucleic Acid Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Blood Biomarker Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global In-vitro Colorectal Cancer Screening Tests Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global In-vitro Colorectal Cancer Screening Tests Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Thermo Fisher Scientific Inc. Financial Performance
  • Table 80: Abbott Laboratories Financial Performance
  • Table 81: Siemens Healthineers Financial Performance
  • Table 82: Quest Diagnostics Incorporated Financial Performance
  • Table 83: Roche Diagnostics International AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Fecal Occult Blood Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Stool Deoxyribonucleic Acid Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Blood Biomarker Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global In-vitro Colorectal Cancer Screening Tests Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global In-vitro Colorectal Cancer Screening Tests Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 80: Abbott Laboratories Financial Performance
  • Figure 81: Siemens Healthineers Financial Performance
  • Figure 82: Quest Diagnostics Incorporated Financial Performance
  • Figure 83: Roche Diagnostics International AG Financial Performance

Frequently Asked Questions

In-vitro colorectal cancer screening tests are non-invasive laboratory-based tests that analyze stool or blood samples to detect signs of colorectal cancer or precancerous conditions. These tests help detect early signs of colorectal cancer in asymptomatic individuals, enabling early intervention and reducing cancer-related mortality. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Colorectal Cancer Fueling The Growth Of The Market Due To Increasing Risk From Unhealthy Lifestyles. For further insights on this market, request a sample here

The in-vitro colorectal cancer screening tests market size has grown strongly in recent years. It will grow from $1.21 billion in 2024 to $1.30 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing awareness of early cancer detection, rise in government screening programs, increasing adoption of non-invasive testing methods, growing healthcare expenditure, and increasing availability of at-home screening kits. The in-vitro colorectal cancer screening tests market size is expected to see strong growth in the next few years. It will grow to $1.71 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing focus on personalized medicine, rising demand for cost-effective diagnostics, growing investments in cancer research, rising adoption of molecular diagnostic techniques, increasing prevalence of colorectal cancer, and increasing accessibility of testing in emerging markets. Major trends in the forecast period include advancement in liquid biopsy technologies, innovation in biomarker discovery, integration of artificial intelligence in test analysis, advanced development of multi-target stool deoxyribonucleic acid tests, innovation in sample collection and processing, advancement in automation and digital pathology, and integration of cloud-based diagnostic platforms. For further insights on this market, request a sample here

The in-vitro colorectal cancer screening tests market covered in this report is segmented
1) By Test Type: Fecal Occult Blood Test, Stool Deoxyribonucleic Acid Test, Blood Biomarker Test, Other Test Types
2) By Imaging Type: Colonoscopy, Proctoscopy, Computed Tomography Scan, Ultrasound, Magnetic Resonance Imaging, Positron Emission Tomography Scan
3) By Application: Screening, Diagnosis, Monitoring, Risk Assessment, Post-Treatment Surveillance
4) By End User: Hospitals, Diagnostic Laboratories, Outpatient Clinics, Home Care Settings, Research Institutions Subsegments:
1) By Fecal Occult Blood Test: Guaiac Based Fecal Occult Blood Test, Immunochemical Fecal Occult Blood Test
2) By Stool Deoxyribonucleic Acid Test: Single Target Stool Deoxyribonucleic Acid Test, Multi Target Stool Deoxyribonucleic Acid Test
3) By Blood Biomarker Test: Methylated Septin 9 Deoxyribonucleic Acid Test, Circulating Tumor Deoxyribonucleic Acid Test, Protein Biomarker Based Blood Test
4) By Other Test Types: Urine Based Biomarker Test, Serum Based Biomarker Test, Breath Based Volatile Organic Compound Test For further insights on this market,
request a sample here

North America was the largest region in the in-vitro colorectal cancer screening tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro colorectal cancer screening tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the in-vitro colorectal cancer screening tests market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Quest Diagnostics Incorporated, Roche Diagnostics International AG, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Natera Inc., Leica Biosystems Nussloch GmbH, BGI Genomics Co. Ltd., NeoGenomics Inc., Guardant Health Inc., CellMax Life Inc., Epigenomics AG, Acuamark Diagnostics Inc., Beacon Biomedical Inc., Mainz Biomed NV. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Non-Invasive Test Enhances Patient Screening Experience. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon